Cory Abate-Shen, PhD - Columbia University
Julien Sage, PhD - Stanford University
Meeting #: Refer to your packet.
Hours: 8:00am – 8:00 pm EST M-F
International : 623-516-6140
Asilomar Conference Grounds
800 Asilomar Avenue
Pacific Grove, CA 93950
Neuroendocrine cancer is an umbrella term for a group of tumors in which cancer cells have the particularity of displaying traits similar to those of both nerve cells and hormone-producing cells. Neuroendocrine tumors can occur in many tissues and organs in the human body, including the lung, the pancreas, the prostate, or the skin. Some neuroendocrine tumors are very rare, others are more frequent; some are indolent, while others are extremely aggressive and fatal. Historically, neuroendocrine tumors have been studied and treated in the context of the specific site in which they were found. More recently, however, accumulating evidence has indicated that neuroendocrine tumors from various sites shared a number of important features, especially in terms of oncogenic drivers. A major goal of the meeting will thus be to discuss the biology and clinical aspects of neuroendocrine tumors to understand the differences and similarities between these tumors in different organs and tissues. We hope to arrive at a consensus about how to distinguish and define this group of tumors, and hopefully identify a framework to develop future therapeutic strategies that may help all patients with neuroendocrine cancer.
|Cory Abate-Shen, PhD||Columbia University Irving Medical Center|
|Suzanne Baker, PhD||St. Jude Children's Research Center|
|Andrea Califano, PhD||Columbia University|
|James DeCaprio, MD||Dana-Farber Cancer Institute, Harvard Medical School|
|Julie George, PhD||University of Cologne|
|Andrew Goldstein, PhD||University of California Los Angeles|
|Jane Johnson, PhD||UT Southwestern Medical Center|
|Claire Magnon, PharmD, PhD||ICRM Paris|
|David McConkey, PhD||Johns Hopkins Medicine|
|Edward Morrisey, PhD||University of Pennsylvania|
|Peter Nelson, MD||Fred Hutchinson Cancer Research Center|
|Trudy Oliver, PhD||University of Utah & Huntsman Cancer Institute|
|Jayaraj Rajagopal, MD||Massachusetts General Hospital|
|Mark Rubin, PhD||University of Bern|
|Julien Sage, PhD||Stanford University|
|Xin Sun, PhD||University of California San Diego|
|Eric Gardner, PhD||Weill Cornell Medicine|
|Catherine Meador, MD||Massachusetts General Hospital Cancer Center|
|Nitin Roper, MD||National Cancer Institute|
The Monterey Regional Airport (MRY) is the preferred airport as it is only 20 minutes from the meeting location.
Mineta San Jose International (SJC) is 1 1/2 hours from the meeting location without traffic. The Foundation can only accommodate 1 pick up per day at San Jose. If you absolutely must fly into San Jose (ie: International Flights) the Foundation will have the following pick up times:
San Francisco International Airport (SFO) is 2 hours from the meeting location without traffic. The Foundation can only accommodate 1 pick up per day at San Francisco. If you absolutely must fly into San Francisco (ie: International Flights) the Foundation will have the following pick up times:
The abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.Submit Abstract
For more than 30 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!